Partnership expansion Strive Compounding Pharmacy has active collaboration activity with healthcare providers and strategic partners, including a recent alliance with LTR Pharma for erectile dysfunction treatment. This indicates opportunity to pursue expanded co-development or co-promotion arrangements with clinics, specialty centers, and pharmaceutical distributors seeking personalized medicine capabilities.

Geographic growth The company expanded facilities to Florida, signaling aggressive geographic expansion and capacity growth. This presents a sales focus on regionally focused supply chain solutions, local compliance support, and site-specific manufacturing capacity to meet rising demand in the southeastern United States and beyond.

Product portfolio A broad, patient-centric product suite including hormone replacement, weight management, dermatology, veterinary care, NAD+ therapies, and Flex-Dose formulations points to cross-sell opportunities across clinics and wellness programs, as well as potential partnerships with specialty pharmacies, clinics, and veterinary practices seeking customized compounding solutions.

Technology enablement The use of analytics and collaboration tools such as Grafana, Power BI, Tableau, and Asana indicates data-driven operations and scalable workflow management. This creates a sales angle around enterprise support services, reporting capabilities, and IT-enabled manufacturing partnerships for enhanced traceability, quality assurance, and provider dashboards.

Competitive and risk signals Legal action against Novo Nordisk and active litigation about competition suggests a competitive environment and ongoing IP or market access considerations. This signals opportunities to position Strive as a trusted partner for compliance-driven manufacturers and healthcare systems seeking robust risk management, regulatory support, and reliable supply of personalized medications.